Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

China flag China · Delayed Price · Currency is CNY
14.23
+0.28 (2.01%)
Apr 29, 2026, 3:04 PM CST
4.10%
Market Cap 8.36B
Revenue (ttm) 2.05B
Net Income (ttm) 433.13M
Shares Out 587.57M
EPS (ttm) 0.74
PE Ratio 19.23
Forward PE n/a
Dividend 0.55 (3.94%)
Ex-Dividend Date Nov 19, 2025
Volume 2,424,580
Average Volume 2,375,485
Open 14.12
Previous Close 13.95
Day's Range 13.95 - 14.27
52-Week Range 13.13 - 17.38
Beta 0.30
RSI 52.44
Earnings Date Apr 29, 2026

About SHE:002275

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China and internationally. The company offers three gold particles, Guilin watermelon frost, watermelon frost lozenges, throat clearing spray, Naomaitai capsules, vertigo tablets, Xuanyunning granules, Gejie dingchuan capsule, compound panax notoginseng stomachache capsule, compound panax notoginseng stomach pain tablets, Sanqi xueshangning capsules, Sanqi xueshangning powder, compound luo han guo qing fei granule... [Read more]

Sector Healthcare
Founded 1985
Employees 2,567
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002275
Full Company Profile

Financial Performance

In 2025, SHE:002275's revenue was 2.05 billion, a decrease of -6.76% compared to the previous year's 2.19 billion. Earnings were 433.13 million, a decrease of -16.95%.

Financial Statements

News

There is no news available yet.